Page 2 - Propionic Acidemia News Today

03.11.2022 - - Reported positive preclinical data for its next-generation KRASG12C GTP/GDP dual inhibitor development candidate, BBO-8520, and for its novel PI3Kα:RAS breaker mechanism in late lead optimization - Reported positive updated 12-month Phase 2 data ...

This industry insight explores the findings from a comparative analysis of specific policies governing periodic updates to NBS panels in 30 European countries.

The Sh60 billion Moderna plant in Kenya will have the capacity to manufacture 500 million vaccines annually.

The Sh60 billion Moderna plant in Kenya will have the capacity to manufacture 500 million vaccines annually.

Q4 2021 revenues of $7.2 billion; GAAP net-income of $4.9 billion and GAAP diluted EPS of $11.29Full year 2021 revenues of $18.5 billion; GAAP net-income of $12.2 billion and GAAP diluted EPS of $28.29Moderna

In a time span of two months, the child underwent four surgeries that include a liver transplant, mesh placement, mesh replacement and mesh removal.

Eleven-month-old boy suffering from metabolic liver disorder treated after 4 surgeries

Eleven-month-old boy from Oman, suffering from Propionic Acidemia, a metabolic liver disorder leading to toxicity in the blood, was treated in India after four successful surgeries.

Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates Read full article Oops! SARS-CoV-2 Variant Booster Program Update : Single booster dose of 50 µg of mRNA-1273 or mRNA-1273.351 increased neutralizing titers against SARS-CoV-2 and two Variants of Concern (B.1.351, P.1) in previously vaccinated clinical trial participants TeenCOVE Study Update : Initial analysis of the Phase 2/3 TeenCOVE study of mRNA-1273 showed vaccine efficacy against COVID-19 of 9...